The directors of Advanced Health announced shareholders that, in respect of the unaudited consolidated interim results for the period ended 31 December 2020, the loss per share is expected to be 2.90 cents for the period ended 31 December 2020 compared to a loss per share of 7.47 cents for the comparative period ended 31 December 2019.